Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers

NCT04601844 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pozelimab
DRUG: Cemdisiran

Sponsor

Regeneron Pharmaceuticals

Collaborators

[object Object]